Synapse - Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes

Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes Meeting Abstract

Authors:	Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Escamilla, M. S.; Scordo, M.; Shah, G. L.; Barker, J. N.; Castro-Malaspina, H.; Gyurkocza, B.; Dahi, P. B.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Shouval, R.; Tamari, R.; van den Brink, M. R. M.; Young, J. W.; Giralt, S. A.; Perales, M.
Abstract Title:	Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
Meeting Title:	46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title:	Bone Marrow Transplantation
Volume:	55
Issue:	Suppl. 1
Meeting Dates:	2020 Aug 29-Sept 1
Meeting Location:	Virtual
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2020-12-11
Start Page:	183
End Page:	184
Language:	English
ACCESSION:	WOS:000600556201003
PROVIDER:	wos
PMCID:	PMC7729732
PUBMED:	33311612
Notes:	Meeting Abstract: P003 -- Source: Wos